Miracle Mile Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,050
Closed -$278K 509
2021
Q4
$278K Sell
1,050
-30
-3% -$8.08K 0.01% 382
2021
Q3
$312K Hold
1,080
0.02% 357
2021
Q2
$216K Sell
1,080
-20
-2% -$3.88K 0.01% 355
2021
Q1
$214K Hold
1,100
0.01% 349
2020
Q4
$211K Buy
+1,100
New +$200K 0.01% 344

Other funds holding RGEN

Miracle Mile Advisors's RGEN Position: Q1 2022 in Review

Miracle Mile Advisors sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,050 shares — an estimated $278K sold.

Miracle Mile Advisors first reported a position in RGEN in Q4 2020 and held it in 5 quarters. The position peaked at $312K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Miracle Mile Advisors reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Miracle Mile Advisors sold 1,050 Repligen shares in Q1 2022, an estimated $278K.
  • Miracle Mile Advisors first reported a position in Repligen in Q4 2020 and held it in 5 quarters.
  • Miracle Mile Advisors's Repligen position peaked at $312K in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Miracle Mile Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.